Type 2 diabetes drugs vary in impact on survival
| Overall mortality lower with SGLT-2 inhibitors and GLP-1 agonists than with DPP-4 inhibitors
Related items from OnMedica Use of DPP-4 inhibitors associated with increased risk of IBD |
Powered by WPeMatico
